Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, Höfler D, Gaipl U, Frey B, Schmidt M, Haller F, Horch R, Hartmann A, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: fechner k. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424. Int J Hyperthermia. 2023. PMID: 37611915 Free article.
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome.
Willner A, Fechner K, Agaimy A, Haller F, Eckstein M, Ott OJ, Putz F, Gaipl US, Kersting S, Meidenbauer N, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: fechner k. Strahlenther Onkol. 2021 Dec;197(12):1063-1071. doi: 10.1007/s00066-021-01830-0. Epub 2021 Nov 4. Strahlenther Onkol. 2021. PMID: 34735576 Free PMC article.
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational study.
Singer S, Semrau S, Golcher H, Fechner K, Kallies A, Zapata Bonilla S, Grützmann R, Fietkau R, Kluba T, Jentsch C, Andreou D, Bornhäuser M, Schmitt J, Schuler MK, Eichler M. Singer S, et al. Among authors: fechner k. Radiother Oncol. 2023 Dec;189:109913. doi: 10.1016/j.radonc.2023.109913. Epub 2023 Sep 21. Radiother Oncol. 2023. PMID: 37739319 Free article.
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitals.
Burkhard-Meier A, Grube M, Jurinovic V, Agaimy A, Albertsmeier M, Berclaz LM, Di Gioia D, Dürr HR, von Eisenhart-Rothe R, Eze C, Fechner K, Fey E, Güler SE, Hecker JS, Hendricks A, Keil F, Klein A, Knebel C, Kovács JR, Kunz WG, Lenze U, Lörsch AM, Lutz M, Meidenbauer N, Mogler C, Schmidt-Hegemann NS, Semrau S, Sienel W, Trepel M, Waldschmidt J, Wiegering A, Lindner LH. Burkhard-Meier A, et al. Among authors: fechner k. Eur J Surg Oncol. 2024 Dec;50(12):108619. doi: 10.1016/j.ejso.2024.108619. Epub 2024 Aug 23. Eur J Surg Oncol. 2024. PMID: 39270516 Free article.
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, Bauer S, Billner M, Bösch F, Deinzer CKW, Deventer N, Duprée A, Eckert F, Engel L, Fechner K, Fritzsche H, Gaidzik V, Ghani S, Grützmann R, Guder WK, Hamacher R, Hecker JS, Hendricks A, Hillmann A, Houben P, Hübner G, Ivanyi P, Jentsch C, Jordan M, Kappl P, Kaths M, Kessler T, Kirchberg J, Knebel C, Krempien R, Lehner B, Lenze U, Lindner LH, Lörsch AM, Maguire N, Müller S, Piso P, Potkrajcic V, Reichardt P, Richter S, Schewe S, Schiffmann LM, Scholten F, Striefler JK, Schwarzbach M, Seidensaal K, Semrau S, Szkandera J, Szuszies CJ, Timmermann B, Tuscherer A, Wiegering A, Winkelmann MT, Kaul D, Jakob J. Roohani S, et al. Among authors: fechner k. J Cancer Res Clin Oncol. 2025 Jan 4;151(1):30. doi: 10.1007/s00432-024-06063-z. J Cancer Res Clin Oncol. 2025. PMID: 39755880 Free PMC article.
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Temmink SJD, Peeters KCMJ, Bahadoer RR, Kranenbarg EM, Roodvoets AGH, Melenhorst J, Burger JWA, Wolthuis A, Renehan AG, Figueiredo NL, Pares O, Martling A, Perez RO, Beets GL, van de Velde CJH, Nilsson PJ; International Watch & Wait Database (IWWD) Consortium. Temmink SJD, et al. Br J Surg. 2023 May 16;110(6):676-684. doi: 10.1093/bjs/znad051. Br J Surg. 2023. PMID: 36972213 Free PMC article.
Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer.
Fernandez LM, São Julião GP, Santacruz CC, Renehan AG, Cano-Valderrama O, Beets GL, Azevedo J, Lorente BF, Rancaño RS, Biondo S, Espin-Basany E, Vailati BB, Nilsson PJ, Martling A, Van De Velde CJH, Parvaiz A, Habr-Gama A, Perez RO; International Watch & Wait Database Consortium (IWWD) and the Spanish Rectal Cancer Viking Consortium (VIKINGO); International Watch & Wait Database Consortium (IWWD) & Spanish Rectal Cancer Viking Consortium. Fernandez LM, et al. J Clin Oncol. 2024 Oct 28:JCO2400405. doi: 10.1200/JCO.24.00405. Online ahead of print. J Clin Oncol. 2024. PMID: 39467217
103 results